Latest Pharmaceutical Product Development Stories
Great Point Partners II portfolio company, The Consortium of Rheumatology Researchers of North America, Inc. ("Corrona"), announces the election of Raymond H.
Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct.
BOSTON and NOTTINGHAM, England, July 31, 2014 /PRNewswire/ -- Columbia Laboratories, Inc.
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
RESEARCH TRIANGLE PARK, N.C., June 17, 2014 /PRNewswire-USNewswire/ -- Contract research organizations aren't what they used to be. But they are where they used to be: in North Carolina.
National Asset Services Closes Deal with Pharmaceutical Product Development for 224,979 Square Foot Medical Office Lease AUSTIN, Texas, June 12, 2014 /PRNewswire/ -- National Asset
DUBLIN, Ireland, February 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo) has announced the addition
ALBANY, New York, February 3, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Life Sciences BPO Market [Contract Research
DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/939k6g/healthcare ) have announced the addition of the "Global
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.